Biomarker Technologies Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Biomarker Technologies Market to 2027 - Global Analysis and Forecasts by Product (Consumables, Software and Services, Instruments), Technology (Immunoassay, Cytogenetic, Mass Spectrometry, NGS, PCR, Chromatography, Imaging Technologies, and Others), Application (Cancer, Infectious Disease, Autoimmune Diseases, Neurological, Cardiovascular Disorders, and Others), and Geography

Report Code: TIPRE00003070 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
Biomarkers are biological or molecular indicators that indicate the severity of any diseased condition. These biological markers are measured and evaluated to examine normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. Hence the biomarker technology is used in many scientific fields. In medical field, a biomarker is introduced into an organism as a means to examine organ function or other aspects of health. For example, rubidium chloride, a radioactive isotope is used to assess perfusion of heart muscle. Thus the application of biomarker technology is increasing in the field of science.

The biomarker technologies market is anticipated to grow in the forecast period owing to key factors such as increasing use of biomarkers for disease diagnostics, rising use of biomarkers for drug discovery coupled with high R&D expenditure, increasing life science research activities, increasing application areas of biomarkers and growing incidences of cancer and infectious diseases. However, technical issues related to sample collection and storage and risk of contamination hampers growth of this market.

The "Global Biomarker Technologies Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a focus on the global market trend. The report aims to provide an overview of global biomarker technologies market with detailed market segmentation by product, type, application, end user and geography. The global biomarker technologies market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading biomarker technologies market players and offers key trends and opportunities in the market.

The global biomarker technologies market is segmented on the basis of product, type, application, and research area. Based on product, the biomarker technologies market is segmented as consumables, software and services, instruments. Based on technology, the biomarker technologies market is segmented as immunoassay, cytogenetic, mass spectrometry, NGS, PCR, chromatography, imaging technologies and others. On the basis of application the biomarker technologies market is segmented as cancer, infectious disease, autoimmune diseases, neurological, cardiovascular disorders, and others. The research area segment consists of genomics, proteomics, metabolomics, and others.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Biomarker technologies market based on product, technology application and research area. It also provides market size and forecast till 2027 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The biomarker technologies market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

North America is expected to contribute to the largest share in the biomarker technologies market in the forecast period, due to presence of large number of well-established market players in the U.S., increasing prevalence of cancer, cardiovascular diseases, neurological and autoimmune diseases, and growing aging population are likely to influence the growth of the biomarker technologies market. Also, the growing investments in life science research is expected to boost the biomarker technologies market. However, Asia Pacific region is expected to be the fastest growing region owing to increasing prevalence of chronic diseases and growing focus on development of better diagnostic procedures.

The report analyzes factors affecting biomarker technologies market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the biomarker technologies market in these regions.

The report also includes the profiles of key biomarker technologies companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years. Some of the key players operating in the biomarker technologies market include, Agilent Technologies, Inc, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., WATERS, Pacific Biomarkers, Nordic Bioscience, BD, Illumina, Inc., and Hologic, Inc. among others.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1. Biomarker Technologies Market- By Product
1.3.2. Biomarker Technologies Market- By Technology
1.3.3. Biomarker Technologies Market- By Application
1.3.4. Biomarker Technologies Market- By Region
1.3.4.1. By Country

2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. BIOMARKER TECHNOLOGIES MARKET LANDSCAPE
4.1. MARKET OVERVIEW
4.2. PEST ANALYSIS
4.2.1. North America - PEST Analysis
4.2.2. Europe - PEST Analysis
4.2.3. Asia Pacific - PEST Analysis
4.2.4. Middle East & Africa - PEST Analysis
4.2.5. South and Central America - PEST Analysis

5. BIOMARKER TECHNOLOGIES MARKET- KEY INDUSTRY DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. BIOMARKER TECHNOLOGIES MARKET- GLOBAL ANALYSIS
6.1. BIOMARKER TECHNOLOGIES MARKET - GLOBAL MARKET OVERVIEW
6.2. BIOMARKER TECHNOLOGIES MARKET - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/ MARKET SHARE OF KEY PLAYERS

7. BIOMARKER TECHNOLOGIES MARKET REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. CONSUMABLES MARKET
7.3.1. Overview
7.3.2. Consumables Market Forecast and Analysis (US$ Mn)
7.4. SOFTWARE AND SERVICES MARKET
7.4.1. Overview
7.4.2. Software and Services Market Forecast and Analysis (US$ Mn)
7.5. INSTRUMENTS MARKET
7.5.1. Overview
7.5.2. Instruments Market Forecast and Analysis (US$ Mn)

8. BIOMARKER TECHNOLOGIES MARKET REVENUE AND FORECASTS TO 2027 - TECHNOLOGY
8.1. OVERVIEW
8.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
8.3. IMMUNOASSAY MARKET
8.3.1. Overview
8.3.2. Immunoassay Market Forecast and Analysis (US$ Mn)
8.4. CYTOGENETIC MARKET
8.4.1. Overview
8.4.2. Cytogenetic Market Forecast and Analysis (US$ Mn)
8.5. MASS SPECTROMETRY MARKET
8.5.1. Overview
8.5.2. Mass Spectrometry Market Forecast and Analysis (US$ Mn)
8.6. NGS MARKET
8.6.1. Overview
8.6.2. NGS Market Forecast and Analysis (US$ Mn)
8.7. PCR MARKET
8.7.1. Overview
8.7.2. PCR Market Forecast and Analysis (US$ Mn)
8.8. CHROMATOGRAPHY MARKET
8.8.1. Overview
8.8.2. Chromatography Market Forecast and Analysis (US$ Mn)
8.9. IMAGING TECHNOLOGIES MARKET
8.9.1. Overview
8.9.2. Imaging Technologies Market Forecast and Analysis (US$ Mn)
8.10. OTHERS MARKET
8.10.1. Overview
8.10.2. Others Market Forecast and Analysis (US$ Mn)

9. BIOMARKER TECHNOLOGIES MARKET REVENUE AND FORECASTS TO 2027 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. CANCER MARKET
9.3.1. Overview
9.3.2. Cancer Market Forecast and Analysis (US$ Mn)
9.4. INFECTIOUS DISEASES MARKET
9.4.1. Overview
9.4.2. Infectious Diseases Market Forecast and Analysis (US$ Mn)
9.5. AUTOIMMUNE DISORDERS MARKET
9.5.1. Overview
9.5.2. Autoimmune Disorders Market Forecast and Analysis (US$ Mn)
9.6. NEUROLOGICAL DISORDERS MARKET
9.6.1. Overview
9.6.2. Neurological Disorders Market Forecast and Analysis (US$ Mn)
9.7. CARDIOVASCULAR DISORDERS MARKET
9.7.1. Overview
9.7.2. Cardiovascular Disorders Market Forecast and Analysis (US$ Mn)
9.8. OTHERS MARKET
9.8.1. Overview
9.8.2. Others Market Forecast and Analysis (US$ Mn)

10. BIOMARKER TECHNOLOGIES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA BIOMARKER TECHNOLOGIES MARKET
10.1.1. North America Biomarker Technologies Market Forecasts and Analysis (US$ Mn)
10.1.2. North America Biomarker Technologies Market Forecasts and Analysis - By Product (US$ Mn)
10.1.3. North America Biomarker Technologies Market Forecasts and Analysis - By Technology (US$ Mn)
10.1.4. North America Biomarker Technologies Market Forecasts and Analysis - By Application (US$ Mn)
10.1.5. North America Biomarker Technologies Market Forecasts and Analysis - By Country
10.1.6. US Market Overview
10.1.6.1. US Biomarker Technologies Market Forecasts and Analysis - By Product (US$ Mn)
10.1.6.2. US Biomarker Technologies Market Forecasts and Analysis - By Technology (US$ Mn)
10.1.6.3. US Biomarker Technologies Market Forecasts and Analysis - By Application (US$ Mn)
10.1.7. Canada Market Overview
10.1.7.1. Canada Biomarker Technologies Market Forecasts and Analysis - By Product (US$ Mn)
10.1.7.2. Canada Biomarker Technologies Market Forecasts and Analysis - By Technology (US$ Mn)
10.1.7.3. Canada Biomarker Technologies Market Forecasts and Analysis - By Application (US$ Mn)
10.1.8. Mexico Market Overview
10.1.8.1. Mexico Biomarker Technologies Market Forecasts and Analysis - By Product (US$ Mn)
10.1.8.2. Mexico Biomarker Technologies Market Forecasts and Analysis - By Technology (US$ Mn)
10.1.8.3. Mexico Biomarker Technologies Market Forecasts and Analysis - By Application (US$ Mn)
10.2. EUROPE BIOMARKER TECHNOLOGIES MARKET
10.2.1. Europe Biomarker Technologies Market Forecasts and Analysis (US$ Mn)
10.2.2. Europe Biomarker Technologies Market Forecasts and Analysis - By Product (US$ Mn)
10.2.3. Europe Biomarker Technologies Market Forecasts and Analysis - By Technology (US$ Mn)
10.2.4. Europe Biomarker Technologies Market Forecasts and Analysis - By Application (US$ Mn)
10.2.5. Europe Biomarker Technologies Market Forecasts and Analysis - By Country
10.2.6. UK Market Overview
10.2.6.1. UK Biomarker Technologies Market Forecasts and Analysis - By Product (US$ Mn)
10.2.6.2. UK Biomarker Technologies Market Forecasts and Analysis - By Technology (US$ Mn)
10.2.6.3. UK Biomarker Technologies Market Forecasts and Analysis - By Application (US$ Mn)
10.2.7. Germany Market Overview
10.2.7.1. Germany Biomarker Technologies Market Forecasts and Analysis - By Product (US$ Mn)
10.2.7.2. Germany Biomarker Technologies Market Forecasts and Analysis - By Technology (US$ Mn)
10.2.7.3. Germany Biomarker Technologies Market Forecasts and Analysis - By Application (US$ Mn)
10.2.8. France Market Overview
10.2.8.1. France Biomarker Technologies Market Forecasts and Analysis - By Product (US$ Mn)
10.2.8.2. France Biomarker Technologies Market Forecasts and Analysis - By Technology (US$ Mn)
10.2.8.3. France Biomarker Technologies Market Forecasts and Analysis - By Application (US$ Mn)
10.2.9. Italy Market Overview
10.2.9.1. Italy Biomarker Technologies Market Forecasts and Analysis - By Product (US$ Mn)
10.2.9.2. Italy Biomarker Technologies Market Forecasts and Analysis - By Technology (US$ Mn)
10.2.9.3. Italy Biomarker Technologies Market Forecasts and Analysis - By Application (US$ Mn)
10.2.10. Spain Market Overview
10.2.10.1. Spain Biomarker Technologies Market Forecasts and Analysis - By Product (US$ Mn)
10.2.10.2. Spain Biomarker Technologies Market Forecasts and Analysis - By Technology (US$ Mn)
10.2.10.3. Spain Biomarker Technologies Market Forecasts and Analysis - By Application (US$ Mn)
10.3. ASIA PACIFIC BIOMARKER TECHNOLOGIES MARKET
10.3.1. Asia Pacific Biomarker Technologies Market Forecasts and Analysis (US$ Mn)
10.3.2. Asia Pacific Biomarker Technologies Market Forecasts and Analysis - By Product (US$ Mn)
10.3.3. Asia Pacific Biomarker Technologies Market Forecasts and Analysis - By Technology (US$ Mn)
10.3.4. Asia Pacific Biomarker Technologies Market Forecasts and Analysis - By Application (US$ Mn)
10.3.5. Asia Pacific Biomarker Technologies Market Forecasts and Analysis - By Country
10.3.6. China Market Overview
10.3.6.1. China Biomarker Technologies Market Forecasts and Analysis - By Product (US$ Mn)
10.3.6.2. China Biomarker Technologies Market Forecasts and Analysis - By Technology (US$ Mn)
10.3.6.3. China Biomarker Technologies Market Forecasts and Analysis - By Application (US$ Mn)
10.3.7. Japan Market Overview
10.3.7.1. Japan Biomarker Technologies Market Forecasts and Analysis - By Product (US$ Mn)
10.3.7.2. Japan Biomarker Technologies Market Forecasts and Analysis - By Technology (US$ Mn)
10.3.7.3. Japan Biomarker Technologies Market Forecasts and Analysis - By Application (US$ Mn)
10.3.8. India Market Overview
10.3.8.1. India Biomarker Technologies Market Forecasts and Analysis - By Product (US$ Mn)
10.3.8.2. India Biomarker Technologies Market Forecasts and Analysis - By Technology (US$ Mn)
10.3.8.3. India Biomarker Technologies Market Forecasts and Analysis - By Application (US$ Mn)
10.3.9. South Korea Market Overview
10.3.9.1. South Korea Biomarker Technologies Market Forecasts and Analysis - By Product (US$ Mn)
10.3.9.2. South Korea Biomarker Technologies Market Forecasts and Analysis - By Technology (US$ Mn)
10.3.9.3. South Korea Biomarker Technologies Market Forecasts and Analysis - By Application (US$ Mn)
10.3.10. Australia Market Overview
10.3.10.1. Australia Biomarker Technologies Market Forecasts and Analysis - By Product (US$ Mn)
10.3.10.2. Australia Biomarker Technologies Market Forecasts and Analysis - By Technology (US$ Mn)
10.3.10.3. Australia Biomarker Technologies Market Forecasts and Analysis - By Application (US$ Mn)
10.4. MIDDLE EAST AND AFRICA (MEA) BIOMARKER TECHNOLOGIES MARKET
10.4.1. Middle East and Africa (MEA) Biomarker Technologies Market Forecasts and Analysis (US$ Mn)
10.4.2. Middle East and Africa (MEA) Biomarker Technologies Market Forecasts and Analysis - By Product (US$ Mn)
10.4.3. Middle East and Africa Biomarker Technologies Market Forecasts and Analysis - By Technology (US$ Mn)
10.4.4. Middle East and Africa (MEA) Biomarker Technologies Market Forecasts and Analysis - By Application (US$ Mn)
10.4.5. Middle East and Africa (MEA) Biomarker Technologies Market Forecasts and Analysis - By Country
10.4.6. UAE Market Overview
10.4.6.1. UAE Biomarker Technologies Market Forecasts and Analysis - By Product (US$ Mn)
10.4.6.2. UAE Biomarker Technologies Market Forecasts and Analysis - By Technology (US$ Mn)
10.4.6.3. UAE Biomarker Technologies Market Forecasts and Analysis - By Application (US$ Mn)
10.4.7. Saudi Arabia Market Overview
10.4.7.1. Saudi Arabia Biomarker Technologies Market Forecasts and Analysis - By Product (US$ Mn)
10.4.7.2. Saudi Arabia Biomarker Technologies Market Forecasts and Analysis - By Technology (US$ Mn)
10.4.7.3. Saudi Arabia Biomarker Technologies Market Forecasts and Analysis - By Application (US$ Mn)
10.4.8. South Africa Market Overview
10.4.8.1. South Africa Biomarker Technologies Market Forecasts and Analysis - By Product (US$ Mn)
10.4.8.2. South Africa Biomarker Technologies Market Forecasts and Analysis - By Technology (US$ Mn)
10.4.8.3. South Africa Biomarker Technologies Market Forecasts and Analysis - By Application (US$ Mn)
10.5. SOUTH AND CENTRAL AMERICA BIOMARKER TECHNOLOGIES MARKET
10.5.1. South and Central America Biomarker Technologies Market Forecasts and Analysis (US$ Mn)
10.5.2. South and Central America Biomarker Technologies Market Forecasts and Analysis - By Product (US$ Mn)
10.5.3. South and Central America Biomarker Technologies Market Forecasts and Analysis - By Technology (US$ Mn)
10.5.4. South and Central America Biomarker Technologies Market Forecasts and Analysis - By Application (US$ Mn)
10.5.5. South and Central America Biomarker Technologies Market Forecasts and Analysis - By Country
10.5.6. Brazil Market Overview
10.5.6.1. Brazil Biomarker Technologies Market Forecasts and Analysis - By Product (US$ Mn)
10.5.6.2. Brazil Biomarker Technologies Market Forecasts and Analysis - By Technology (US$ Mn)
10.5.6.3. Brazil Biomarker Technologies Market Forecasts and Analysis - By Application (US$ Mn)
10.5.7. Argentina Market Overview
10.5.7.1. Argentina Biomarker Technologies Market Forecasts and Analysis - By Product (US$ Mn)
10.5.7.2. Argentina Biomarker Technologies Market Forecasts and Analysis - By Technology (US$ Mn)
10.5.7.3. Argentina Biomarker Technologies Market Forecasts and Analysis - By Application (US$ Mn)
11. INDUSTRY LANDSCAPE
11.1. ORGANIC GROWTH STRATEGIES
11.1.1. New Product Launches
11.1.2. Marketing & Promotional Activities
11.2. INORGANIC GROWTH STRATEGIES
11.2.1. Partnerships, Collaborations, and Joint Ventures
11.2.2. Mergers & Acquisitions

12. BIOMARKER TECHNOLOGIES MARKET, KEY COMPANY PROFILES
12.1. THERMO FISHER SCIENTIFIC INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Financial Overview
12.1.4. Product Portfolio
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. AGILENT TECHNOLOGIES, INC
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Financial Overview
12.2.4. Product Portfolio
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. WATERS.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Financial Overview
12.3.4. Product Portfolio
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. PACIFIC BIOMARKERS
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Financial Overview
12.4.4. Product Portfolio
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. BD
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Financial Overview
12.5.4. Product Portfolio
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. F. HOFFMANN-LA ROCHE LTD.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Financial Overview
12.6.4. Product Portfolio
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. ILLUMINA, INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Financial Overview
12.7.4. Product Portfolio
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. HOLOGIC, INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Financial Overview
12.8.4. Product Portfolio
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. NORDIC BIOSCIENCE
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Financial Overview
12.9.4. Product Portfolio
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. BIO-RAD LABORATORIES, INC
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Financial Overview
12.10.4. Product Portfolio
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Agilent Technologies, Inc
2. Thermo Fisher Scientific Inc.
3. F. Hoffmann-La Roche Ltd.
4. Bio-Rad Laboratories, Inc.
5. WATERS
6. Pacific Biomarkers
7. Nordic Bioscience
8. BD
9. Illumina, Inc.
10. Hologic, Inc.